---
title: AMR Action Fund Expands Portfolio with Two New Investments
description: The AMR Action Fund announces two new investments.
---

 April 27, 2023

[Press Releases](https://www.amractionfund.com/blog/tag/press-releases)

# AMR Action Fund Expands Portfolio with Two New Investments

April 27, 2023, Boston, MA: The AMR Action Fund announced this week that it has invested in Vedanta Biosciences and Pattern Bioscience.

Vedanta Biosciences is a clinical-stage company whose lead candidate, VE303, is in development for the prevention of recurrent *Clostridioides difficile* infection, which the U.S. Centers for Disease Control and Prevention has classified as an “urgent threat.”

It is estimated that approximately 500,000 *C. difficile* infections occur each year in the U.S., causing tens of thousands of deaths. To take on this growing health threat, Vedanta is developing a potential new category of oral therapies based on defined bacterial consortia. The company said that one of the primary uses of the funding will be to launch a pivotal Phase 3 trial in recurrent *C. difficile* infections.

Pattern Bioscience is developing a diagnostics platform to rapidly identify bacterial pathogens and determine their antibiotic susceptibility. The company’s novel technology is based on single-cell analysis of microorganisms combined with machine learning tools.

The lack of rapid diagnostics and susceptibility testing is a significant challenge globally that imperils patients and undermines antibiotic stewardship efforts. Current standard-of-care cultures can take up to four days to provide a definitive diagnosis for critically ill patients. Pattern’s aim is to develop a platform that can deliver accurate results in a matter of hours.

To learn more about our investment in Vedanta, [please click here](https://www.vedantabio.com/news-media/press-releases/detail/2959/vedanta-biosciences-announces-106-5-million-financing-to).

To learn more about our investment into Pattern, [please click here](https://pattern.bio/pattern-bioscience-secures-28-7-million-in-series-c-financing/).

For more information contact Chris Sweeney: chris.sweeney@amractionfund.com.

![](https://www.amractionfund.com/hubfs/raw_assets/public/amr-action-fund/images/contact-bg-img.png)

## Connect With Us

[ Contact ](https://www.amractionfund.com/blog/fund-expands-portfolio-with-two-new-investments#)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "admin",
    "url" : "https://www.amractionfund.com/blog/author/admin"
  },
  "dateModified" : "2023-08-28T18:49:06.620Z",
  "datePublished" : "2023-04-27T13:01:36.000Z",
  "headline" : "AMR Action Fund Expands Portfolio with Two New Investments",
  "mainEntityOfPage" : {
    "@id" : "https://www.amractionfund.com/blog/fund-expands-portfolio-with-two-new-investments",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject"
    }
  }
}
```